{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T14:13:34Z","timestamp":1653315214136},"reference-count":12,"publisher":"Mark Allen Group","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Nurs"],"published-print":{"date-parts":[[2013,1,9]]},"abstract":"<jats:p> Meningitis, defined as the inflammation of the lining surrounding the spine and the brain, can be caused by bacteria, viruses and fungi. Bacterial meningitis is the most serious form of the disease, causing around 170 000 deaths worldwide each year. Most cases of bacterial meningitis are caused by three bacteria\u2014Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae type B. In the UK, vaccines are available to combat most of these, yet, according to the Meningitis Research Foundation, around 3400 cases of bacterial meningitis and septicaemia occur every year in the UK and the Republic of Ireland. This article reviews the history of vaccination against meningitis, explores the challenges facing nurses who are at the interface of immunisation policy and public expectations, outlines the current schedule and discusses advances in vaccine technology that offer the potential of a new immunisation against N meningitidis B, the leading cause of meningitis in the UK. <\/jats:p>","DOI":"10.12968\/bjon.2013.22.1.20","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T12:46:39Z","timestamp":1400849199000},"page":"20-25","source":"Crossref","is-referenced-by-count":2,"title":["Meninigitis immunisation: challenges, successes and new developments"],"prefix":"10.12968","volume":"22","author":[{"given":"Jacqueline","family":"Boulton","sequence":"first","affiliation":[{"name":"Florence Nightingale School of Nursing and Midwifery, King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5130","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800058155"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.1.332-337.2004"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00529-09"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01109.x"},{"key":"B5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B978-1-4160-3611-1.50023-4","volume-title":"Vaccines","author":"Granoff DM","year":"2008","edition":"5"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11991-X"},{"key":"B14","volume-title":"Meningitis UK Commission Survey\u2014Shocking Results","author":"Meningitis UK","year":"2007"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.1.124"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.09.017"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.071"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"}],"container-title":["British Journal of Nursing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/pdf\/10.12968\/bjon.2013.22.1.20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T13:46:42Z","timestamp":1653313602000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.magonlinelibrary.com\/doi\/10.12968\/bjon.2013.22.1.20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,9]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1,9]]}},"alternative-id":["10.12968\/bjon.2013.22.1.20"],"URL":"https:\/\/doi.org\/10.12968\/bjon.2013.22.1.20","relation":{},"ISSN":["0966-0461","2052-2819"],"issn-type":[{"value":"0966-0461","type":"print"},{"value":"2052-2819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,9]]}}}